Cerebrolysin Protects Brain Cells After Hemorrhagic Stroke by Blocking a Cell Death Pathway
Cerebrolysin improved survival and brain function in mice after brain hemorrhage by inhibiting necroptosis, a programmed cell death mechanism, through the Akt/GSK3β signaling pathway.
Quick Facts
What This Study Found
Cerebrolysin (CBL) treatment significantly improved outcomes after intracerebral hemorrhage (brain bleeding) in mice. Treated mice showed increased survival rates, better neurological scores, and greater neuron survival compared to untreated controls.
The protective mechanism involved inhibition of necroptosis — a form of programmed cell death. Cerebrolysin reduced the expression of RIP1 and RIP3 proteins, which are key drivers of necroptosis, through activation of the Akt/GSK3β signaling pathway. This suggests cerebrolysin protects brain cells not just by supporting their growth, but by actively blocking the cell death pathway that kills neurons after a brain hemorrhage.
Key Numbers
C57BL/6 mouse model · increased survival rate · improved neurological scores · reduced RIP1/RIP3 expression · Akt/GSK3β pathway
How They Did This
Researchers induced intracerebral hemorrhage in C57BL/6 mice and treated them with cerebrolysin. They assessed outcomes using mortality rates, neurological scoring, brain water content (edema), and TUNEL staining (to detect dying cells). Evans blue extravasation measured blood-brain barrier damage. Western blotting and quantitative PCR analyzed the expression of necroptosis markers (RIP1, RIP3) and Akt/GSK3β pathway components.
Why This Research Matters
Intracerebral hemorrhage (bleeding within the brain) is one of the deadliest types of stroke, with limited treatment options. Much of the brain damage occurs not from the initial bleed but from secondary injury — inflammation and cell death cascading outward from the hemorrhage site. This study shows that cerebrolysin, a peptide mixture already used clinically as a neurotrophic agent, can reduce this secondary damage by blocking necroptosis. Identifying the specific molecular pathway (Akt/GSK3β) provides a mechanistic basis for potential clinical trials.
The Bigger Picture
Cerebrolysin is one of the few peptide-based therapies that has been studied for multiple types of brain injury, including ischemic stroke, traumatic brain injury, and now hemorrhagic stroke. While its clinical evidence remains debated in the West, it is widely used in parts of Asia and Europe. This study adds to the mechanistic understanding of how it works — specifically through anti-necroptotic effects — which could help design more targeted peptide neuroprotectants and better-designed clinical trials.
What This Study Doesn't Tell Us
This is a mouse study, and results may not translate directly to human intracerebral hemorrhage. The abstract does not provide specific group sizes or dose details. Cerebrolysin is a complex peptide mixture, making it difficult to attribute effects to specific components. The study was published in a lower-impact journal. The exact timing and duration of treatment are not detailed in the abstract.
Questions This Raises
- ?Can these neuroprotective effects be replicated in human intracerebral hemorrhage patients?
- ?Which specific peptide components within cerebrolysin's complex mixture are responsible for the anti-necroptotic effect?
- ?What is the therapeutic time window — how soon after hemorrhage must cerebrolysin be administered to be effective?
Trust & Context
- Key Stat:
- Necroptosis inhibition Cerebrolysin reduced expression of RIP1 and RIP3 — key necroptosis proteins — in brain tissue after hemorrhage, providing a molecular mechanism for its neuroprotective effects
- Evidence Grade:
- This is rated Preliminary because it is a single animal study in mice with no human data. While the mechanistic detail is valuable, translation to clinical use for brain hemorrhage would require significant additional research.
- Study Age:
- Published in 2021, this is a recent addition to the cerebrolysin literature. The necroptosis mechanism adds to earlier studies examining cerebrolysin's neurotrophic and anti-apoptotic properties.
- Original Title:
- The neuroprotection of cerebrolysin after spontaneous intracerebral hemorrhage through regulates necroptosis via Akt/ GSK3β signaling pathway.
- Published In:
- Acta cirurgica brasileira, 36(10), e361002 (2021)
- Authors:
- Tao, Yunna, Xu, Yeping, Shen, Meng, Feng, Xiaoyan, Wu, Yan, Wu, Youping, Shen, Liuyan, Wang, Yuhai
- Database ID:
- RPEP-05810
Evidence Hierarchy
Frequently Asked Questions
What is cerebrolysin?
Cerebrolysin is a mixture of brain-derived peptides and amino acids obtained from pig brain tissue. It's used clinically in some countries as a neurotrophic agent — meaning it supports brain cell growth and survival. It has been studied for stroke, Alzheimer's disease, traumatic brain injury, and other neurological conditions, though its evidence base remains more established in some regions than others.
What is necroptosis and why does it matter for brain injury?
Necroptosis is a form of programmed cell death that's different from the better-known apoptosis. While apoptosis is a quiet, orderly cell death, necroptosis is more inflammatory — dying cells release their contents, triggering further damage. After a brain hemorrhage, necroptosis can spread damage beyond the initial injury site, so blocking it could significantly reduce brain damage.
Read More on RethinkPeptides
Cite This Study
https://rethinkpeptides.com/research/RPEP-05810APA
Tao, Yunna; Xu, Yeping; Shen, Meng; Feng, Xiaoyan; Wu, Yan; Wu, Youping; Shen, Liuyan; Wang, Yuhai. (2021). The neuroprotection of cerebrolysin after spontaneous intracerebral hemorrhage through regulates necroptosis via Akt/ GSK3β signaling pathway.. Acta cirurgica brasileira, 36(10), e361002. https://doi.org/10.1590/ACB361002
MLA
Tao, Yunna, et al. "The neuroprotection of cerebrolysin after spontaneous intracerebral hemorrhage through regulates necroptosis via Akt/ GSK3β signaling pathway.." Acta cirurgica brasileira, 2021. https://doi.org/10.1590/ACB361002
RethinkPeptides
RethinkPeptides Research Database. "The neuroprotection of cerebrolysin after spontaneous intrac..." RPEP-05810. Retrieved from https://rethinkpeptides.com/research/tao-2021-the-neuroprotection-of-cerebrolysin
Access the Original Study
Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.
This study breakdown was produced by the RethinkPeptides research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.